KRAS and cancer: These substitution specific downstream effects might explain the differences between the substitutions with regard to prognosis13, 14, 15 and treatment response16, 17, 18, 19 and have led to the development of anti-cancer treatments that target specific KRAS-substitution-subtypes20.